Immunocytological detection of isolated tumour cells in the bone marrow of malignant melanoma patients: A new method for the detection of minimal residual disease

European Journal of Surgical Oncology

Volumn 25, Issue 5, 1999, Pages 498-502

  Thybusch Bernhardt, A ^a   Klomp, H J ^a   Maas, T ^a   Kremer, B ^a   Juhl, H ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

Immunocytology; Malignant melanoma; Minimal residual disease

Indexed keywords

MONOCLONAL ANTIBODY HMB 45; PEROXIDASE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MELANOMA; MINIMAL RESIDUAL DISEASE; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; TECHNIQUE; TUMOR CELL;

EID: 0032844193     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.1999.0685     Document Type: Article

References (32)

1. Becker, N, Wahrendorf, J, Melanoma, In: Becker N, Wahrendorf J (eds). Atlas of Cancer Mortality in the Federal Republic of Germany 1981-1990 3rd edn. Berlin: Springer, 1998: 338-64.
2. Balch, CB, Houghton, AN, 37: Diagnosis of Metastatic Melanomas at Distant Sites, In: Balch CB (ed.) Cutaneous Melanoma. Philadelphia, PA: JB Lippincott Co, 1992: 439-67.
3. Guo Y, Ma J, Wang J, Che X, Narula J, Bigby M, Wu M, Sy MS. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res. 54:1994;1561-1565.
4. Salgaller ML, Marincola FM, Cormier JN, Rosenberg SA. Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides. Cancer Res. 56:1996;4749-4757.
5. Molino A, Colombatti M, Bonetti F, Zardini M, Pasini F, Perini A, Pelosi G, Tridente G, Veneri D, Cetto GL. A comparative analysis of three different techniques or the detection of breast cancer cells in bone marrow. Cancer. 67:1991;1033-1036.
6. Diel J, Kaufmann M, Goerner R, Costa SD, Kaul S, Bastert G. Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol. 10:1992;1534-1539.
7. Pantel K, Izbicki J, Passlick B, Angstwurm M, Haussinger K, Thetter O, Riethmüller G. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet. 347:1996;649-653.
8. Combaret V, Favrot MC, Kremens B. Immunocytological detection of neuroblastoma cells in bone marrow harvested for autologous transplantation. Br J Cancer. 59:1989;844-847.
9. Riesenberg R, Oberneder R, Kriegmair M, Epp M, Bitzer U, Hofstetter A, Braun S, Riethmüller G, Pantel K. Immunocytological double staining of cytokeratin and prostate specific antigen in individual prostatic tumor cells. Histochemistry. 99:1993;61-66.
10. Schlimok G, Funke I, Pantel K, Strobel F, Lindemann F, Witte J, Riethmüller G. Micrometastatic tumor cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer. 27:1991;1461-1465.
11. Schlimok G, Funke I, Holzmann B. Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytoceratin and in vivo labeling with anti-17-A monoclonal antibodies. Proc Natl Acad Sci USA. 84:1987;8672-8676.
12. Juhl H, Stritzel M, Wroblewski A, Henne-Bruns D, Kremer B, Schmiegel W, Neumaier M, Wagener C, Schreiber HW, Kalthoff H. Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreaatic cancer patients. Int J Cancer. 57:1994;330-335.
13. Diel J, Kaufmann M, Costa SD, Holle R, von Minckwitz G, Solomayer EF, Kaul S, Bastert G. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst. 88:1996;1652-1658.
14. Thorban S, Roder D, Nekarda H, Funk A, Siewert JR, Pantel K. Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma. J Natl Cancer Inst. 88:1996;1222-1227.
15. Lindemann F, Schlimok G, Dirschedel P, Witte J, Riethmüller G. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet. 340:1992;685-689.
16. Schott A, Vogel I, Krueger U, Kalthoff H, Schreiber H-W, Schmiegel W, Henne-Bruns D, Kremer B, Juhl H. Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker. Ann Surg. 227:1998;372-379.
17. Battayani Z, Grob JJ, Xerri L, Noe C, Zarour H, Houvalneghel G, Delpero JL, Birmbaum D, Hassoun J, Bonerandi JJ. Polymerase chain reaction of circulating melanocytes as a prognostic marker in patients with melanoma. Arch Dermatol. 131:1995;443-447.
18. Brossart P, Keilholz U, Willhauck M, Scheibenbogen C, Möhler T, Hunstein W. Hematogenous spread of malignant melanoma cells in different stages of disease. J Invest Dermatol. 101:1993;887-889.
19. Buzaid AC, Balch CM. Polymerase chain reaction for detection of melanoma in peripheral blood: too early to assess clinical value. J Natl Cancer Inst. 88:1996;569-570.
20. Farthmann B, Eberle J, Krasagakis K, Gstöttner M, Wang N, Bisson S, Orfanos CE. RT-PCR for tyrosine-mRNA-positive cells in peripheral blood: evaluation strategy and correlation with known prognostic markers in 123 melanoma patients. J Invest Dermatol. 110:1998;263-267.
21. Foss AJ, Guille MJ, Occleston NL, Hykin PG, Hungerford JL, Lightman S. The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction. Br J Cancer. 72:1995;155-159.
22. Ghossein RA, Coit D, Brennan M, Zhang ZF, Wang Y, Bhattacharya S, Houghton A, Rosai J. Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma. Clin Cancer Res. 4:1998;419-428.
23. Gläser R, Rass K, Seiter S, Hausschildt A, Christophers E, Tilgen W. Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: a clinical two-center study. J Clin Oncol. 15:1997;2818-2825.
24. Mellado B, Colomer D, Castel T, Munoz M, Carbello E, Galan M, Mascaro JM, Vives-Corrons JL, Grau JJ, Estape J. Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis. J Clin Oncol. 14:1996;2091-2097.
25. Reinhold U, Lüdtke-Handjery HC, Schnautz S, Kreysel HW, Abken H. The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression. J Invest Dermatol. 108:1997;166-169.
26. Jung R, Ahmad-Nejad P, Wimmer M, Gerhard M, Wagener C, Neumaier M. Quality management and influential factors for the detection of single metatastic cancer cells by reverse transcriptase polymerase chain reaction. Eur J Clin Chem Clin Biochem. 35:1997;3-10.
27. Pantel K, Schlimok G, Braun S, Kutter D, Lindemann F, Schaller G, Funke I, Izbicki JR, Riethmüller G. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst. 85:1993;1419-1424.
28. Soeth, E, Fischer, I, Beckmann, S, Kremer, B, Henne-Bruns, D, Juhl, H, Phenotypic characterization of disseminated isolated tumor cells in the peritoneal cavity and the bone marrow of gastrointestinal cancer patients, In: Abstract Book of the 15th EACR Meeting. Stockholm, 16-19 August 1998, Brussels: EACR.
29. Kikuchi A, Shimizu H, Nishikawa T. Expression and ultrastructural localization of HMB-45 antigen. Br J Dermatol. 135:1996;400-405.
30. Skelton HG, Smith KJ, Barrett TL, Lupton GP, Graham JH. HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation. Am J Dermatopathol. 13:1991;543-550.
31. Wick MR, Stanley SJ, Swanson PE. Immunohistological diagnosis of sinonasal melanoma, carcinoma and neuro- blastoma with monoclonal antibodies HMB-45 and antisynaptophysin. Arch Pathol Lab Med. 112:1988;616-620.
32. Redding WH, Coombes RC, Monaghan P. Detection of micrometastases in patients with primary breast cancer. Lancet. 2:1983;1271-1274.